WASHINGTON— The world still isn't close to preventing what leaders call a dangerous level of man-made warming, a new United Nations report says. "The time window is closing, closing," said United Nations undersecretary for environment Achim Steiner. Without factoring in this month's promises by the U.S. and China to reduce emissions, the world will be spewing...» Read More
GENEVA, Sept 9- Atmospheric volumes of greenhouse hit a record in 2013 as carbon dioxide concentrations grew at the fastest rate since reliable global records began, the World Meteorological Organization said on Tuesday.
LEVEL OF CARBON DIOXIDE IN THE ATMOSPHERE INCREASED LAST YEAR AT FASTEST RATE SINCE RELIABLE GLOBAL RECORDS BEGAN THREE DECADES AGO.
Soybean planting in Brazil's leading agricultural states is only allowed after Sept. 15, following a period of three months in which the land must be left fallow to avoid the spread of disease in the tropical soil.
CNBC's Meg Tirrell speaks to Johnson & Johnson chairman, Joaquin Duato, about J&J's partnership with the National Institutes of Health to fast track its Ebola vaccine program to begin human testing by early 2015.
Discussing the new ways to monitor glucose for people with diabetes, and competition in the space, with Terry Gregg, DexCom CEO. Gregg says his business is in conversations with Apple and Samsung in regards to partnering on wearables.
CNBC's Meg Tirrell reports an American missionary doctor serving in Liberia has tested positive for Ebola.
Two major tech investors have plowed $1.5 million into Helion Energy to help it develop a technology that hasn’t worked, according to Oilprice.com.
GlaxoSmithKline is to begin human testing of an experimental Ebola vaccine. CNBC's Meg Tirrell reports the World Health Organization has released a response roadmap with the goal of stopping the spread of Ebola in 6 to 9 months.
Kite Pharma is working on a treatment which involves taking a cancer patient's own t-cells out of their body, genetically modifying them to better target cancer, and then re-administering them. Its CEO Arie Belldegrun, provides insight to the positive study with the therapy.
Aug 25- A package of bills aimed at regulating drought-parched California's stressed groundwater supplies has come under fire from agricultural interests, injecting doubt into the measures' fates in the waning days of the state's legislative session this week.
CNBC's Meg Tirrell breaks down the mega deal between Swiss pharmaceutical firm Roche and InterMune for $8.3 billion.
CNBC's Meg Tirrell speaks to Roche CEO Severin Schwan, and InterMune CEO Daniel Welch, about Roche's $8.3 billion acquisition of InterMune and the opportunity for the drug Esbriet in the U.S.
California's mountains have risen more than half an inch, thanks to the absence of water to weigh them down, a study found. NBC News reports.
CNBC's Andrew Ross Sorkin looks back on some of the best ice bucket challenge videos from last week, including from Bill Gates, saying the campaign has now hit China.
Lance Slaughter from the ALS Association, discusses the phenomenon spreading across social media to dump a bucket of ice over your head to raise awareness for ALS.
CNBC's Meg Tirrell explains what ALS, or Lou Gehrig's disease is, and what is known about treating the disease.
CNBC looks at which countries may be worst hit, both environmentally and economically, by climate change.
Is the world ready for genetically modified babies? Here's how close we really are, explains Jessica Cussins of the Center for Genetics and Society.
CNBC's Meg Tirrell reports the World Health Organization has convened a panel of medical ethicists to discuss the potential treatment for Ebola patients with experimental therapies.
With the World Health Organization declaring Ebola an international public health emergency, CNBC's Meg Tirrell discusses the use of experimental drugs as a last resort to treat patients stricken with Ebola, cancer and other disease.